Accelerated biological aging in COVID-19 patients
Covid Lists
Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors
Berberine reduces circulating inflammatory mediators in patients with severe COVID-19 | British Journal of Surgery | Oxford Academic
Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
anticoagulant-triple-therapy.pdf
Study Details | Antiviral Clinical Trial for Long Covid-19 | ClinicalTrials.gov
RU2297846C2 - Method for treatment of focal and infiltrative pulmonary tuberculosis - Google Patents
Masks and respirators for prevention of respiratory infections: a state of the science review | Clinical Microbiology Reviews
US State Restrictions and Excess COVID-19 Pandemic Deaths
Lives saved and lost in the first six month of the US COVID-19 pandemic: A retrospective cost-benefit analysis
Does Tenofovir Disoproxil Fumarate Mitigate COVID-19 Outcomes in Men with HIV?
Tenofovir and COVID: The Jury Is Still Out
Effect of Tenofovir Disoproxil Fumarate and Emtricitabine on nasopharyngeal SARS-CoV-2 viral load burden amongst outpatients with COVID-19: A pilot, randomized, open-label phase 2 trial
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B
‘Old style’ tenofovir really may protect against COVID, large US study finds
Tenofovir-Containing Antiretroviral Therapy and Clinical Outcomes of SARS-CoV-2 Infection in People Living with HIV
Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B - BMC Infectious Diseases
Common HIV medication associated with improved COVID-19 outcomes
Dose matters: HIV drug could prevent coronaviruses, study finds
Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
Azvudine versus Paxlovid in COVID‐19: A systematic review and meta‐analysis
Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients - BMC Infectious Diseases
Research shows how HIV drug could stop many coronavirus diseases
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis
Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
Effectiveness and safety of azvudine in older adults with mild and moderate COVID-19: a retrospective observational study - BMC Infectious Diseases
Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study